AngioDynamics Announces Secondary Offering Of 2,250,000 Shares Of Common Stock By Selling Stockholders

AngioDynamics, Inc. (Nasdaq: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that Avista Capital Partners, LP and affiliated investment funds intend to offer for sale 2,250,000 shares of common stock in an underwritten secondary offering, pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission (“SEC”). The selling shareholders will receive all of the net proceeds from the offering. AngioDynamics is not selling any common shares in the offering and will not receive any of the proceeds. Cantor Fitzgerald & Co. will act as underwriter for the offering.

A shelf registration statement (including a prospectus) relating to the offering of common stock was filed with the SEC on October 3, 2013 and became effective on October 11, 2013. Before you invest, you should read the prospectus included in that registration statement and the documents incorporated by reference in that registration statement as well as the prospectus supplement related to this offering. You may obtain these documents for free by visiting EDGAR on the SEC website at www.sec.gov. When available, copies of the prospectus supplement and accompanying prospectus related to the offering may also be obtained by contacting Cantor Fitzgerald & Co., Attn: Capital Markets, 499 Park Ave., 5th Floor, New York, New York 10022, or by telephone at 212-829-7122, or by e-mail at prospectus@cantor.com.

The offering of these securities will be made only by means of a prospectus supplement and the accompanying prospectus.

This release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. Any offer to buy the securities may be withdrawn or revoked, without obligation or commitment of any kind, at any time prior to notice of its acceptance given after the effective date of the shelf registration statement.

1 2 3
View single page >> |

Disclosure: None.

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.